Literature DB >> 3930848

The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption.

D P Muller, J K Lloyd, O H Wolff.   

Abstract

Studies in patients with abetalipoproteinaemia and other chronic and severe fat malabsorptive states, and neuropathological studies in the vitamin E-deficient human, monkey and rat indicate that vitamin E is important for normal neurological function. Appropriate vitamin E supplementation is, therefore, advisable for all patients with chronic fat malabsorption who have low serum vitamin E concentrations.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3930848     DOI： 10.1007/bf01800666

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


  27 in total

1.  ON THE EXISTENCE OF A HITHERTO UNRECOGNIZED DIETARY FACTOR ESSENTIAL FOR REPRODUCTION.

Authors:  H M Evans; K S Bishop
Journal:  Science       Date:  1922-12-08       Impact factor: 47.728

Review 2.  Metabolic roles of fat-soluble vitamins D, E, and K.

Authors:  R H Wasserman; A N Taylor
Journal:  Annu Rev Biochem       Date:  1972       Impact factor: 23.643

3.  Absorption of vitamin E in children with biliary obstruction.

Authors:  J T Harries; D P Muller
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

4.  Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia.

Authors:  D P Muller; J K Lloyd
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  The relative importance of the factors involved in the absorption of vitamin E in children.

Authors:  D P Muller; J T Harries; J K Lloyd
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

6.  Vitamin E and neurological function.

Authors:  D P Muller; J K Lloyd; O H Wolff
Journal:  Lancet       Date:  1983-01-29       Impact factor: 79.321

7.  The neuropathy of abetalipoproteinemia.

Authors:  R G Miller; C J Davis; D R Illingworth; W Bradley
Journal:  Neurology       Date:  1980-12       Impact factor: 9.910

8.  Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: diagnosis and treatment with alpha tocopherol.

Authors:  M A Guggenheim; S P Ringel; A Silverman; B E Grabert
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

9.  Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides.

Authors:  E Azizi; J L Zaidman; J Eshchar; A Szeinberg
Journal:  Acta Paediatr Scand       Date:  1978-11

10.  Nervous and ocular disorders in children with cholestasis and vitamin A and E deficiencies.

Authors:  F Alvarez; P Landrieu; P Laget; F Lemonnier; M Odièvre; D Alagille
Journal:  Hepatology       Date:  1983 May-Jun       Impact factor: 17.425
View more
  13 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

2.  Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

Authors:  Charlotte Cuerq; Emilie Henin; Lioara Restier; Emilie Blond; Jocelyne Drai; Christophe Marçais; Mathilde Di Filippo; Christian Laveille; Marie-Caroline Michalski; Pierre Poinsot; Cyrielle Caussy; Agnès Sassolas; Philippe Moulin; Emmanuelle Reboul; Sybil Charriere; Emile Levy; Alain Lachaux; Noël Peretti
Journal:  J Lipid Res       Date:  2018-07-18       Impact factor: 5.922

Review 3.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

4.  Liver fibrosis in a patient with familial homozygous hypobetalipoproteinaemia: possible role of vitamin supplementation.

Authors:  J Y Scoazec; M E Bouma; J F Roche; D Blache; N Verthier; G Feldmann; G Gay
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 5.  Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management.

Authors:  Jooho Lee; Robert A Hegele
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

Review 6.  Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers.

Authors:  Noel Peretti; Agnès Sassolas; Claude C Roy; Colette Deslandres; Mathilde Charcosset; Justine Castagnetti; Laurence Pugnet-Chardon; Philippe Moulin; Sylvie Labarge; Lise Bouthillier; Alain Lachaux; Emile Levy
Journal:  Orphanet J Rare Dis       Date:  2010-09-29       Impact factor: 4.123

7.  Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Authors:  P H Berry; J S MacDonald; A W Alberts; S Molon-Noblot; J S Chen; C Y Lo; M D Greenspan; H Allen; G Durand-Cavagna; R Jensen
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

8.  Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases.

Authors:  Laurence Chardon; Agnès Sassolas; Bernard Dingeon; Laurence Michel-Calemard; Michel Bovier-Lapierre; Philippe Moulin; Alain Lachaux
Journal:  Eur J Pediatr       Date:  2008-12-09       Impact factor: 3.183

Review 9.  Dosage and formulation issues: oral vitamin E therapy in children.

Authors:  Tone Westergren; Betty Kalikstad
Journal:  Eur J Clin Pharmacol       Date:  2009-10-13       Impact factor: 2.953

10.  Molecular characterization of Tunisian families with abetalipoproteinemia and identification of a novel mutation in MTTP gene.

Authors:  Mohamed Najah; Sarraj Mohamed Youssef; Hrira Mohamed Yahia; Slimani Afef; Jelassi Awatef; Hammami Saber; Najjar Mohamed Fadhel; Agnès Sassolas; Slimane Mohamed Naceur
Journal:  Diagn Pathol       Date:  2013-04-04       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.